Stock Details
TEVA is Teva Pharmaceutical Industries Limited's stock. Stock exchange NYSE (Currency USD). Average price in 50 days is 9.31$. Average daily volumn in 3 months 13.28M. Market cap 9.22B



Stock symbol : TEVA. Exchange : NYSE. Currency : USD
Lastest price : 8.62$. Total volume : 4.92M. Market state REGULAR
Click reload if you want to check the lastest price on market!!!

Teva Pharmaceutical Industries Limited (TEVA)
Last Price
8.62$
Change
0.40
Volume
4.92M

Previous Close8.23
Open8.40
Day Range8.38-8.69
Bid8.65 x 4k
Ask8.66 x 800
Volume4.92M
Average Volume13.28M
Market Cap9.22B
Beta1.27
52 Week Range6.78-11.34
Trailing P/EN/A
Foward P/E3.38
Dividend (Yield %)N/A
Ex-Dividend Date2017-11-27



Financial Details


According to Teva Pharmaceutical Industries Limited's financial reports the company's revenue in 2021 were 15.88B an decrease(-6.25%) over the years 2020 revenue that were of 16.66B. In 2021 the company's total earnings were 417M while total earnings in 2020 were -3.99B(-113.9%).


Loading ...



Organization

Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams. It also develops, manufactures, and sells ac... tive pharmaceutical ingredients. In addition, it focuses on the central nervous system, pain, respiratory, and oncology areas. Its products in the central nervous system include Copaxone for the treatment of relapsing forms of multiple sclerosis; AJOVY for the preventive treatment of migraine; and AUSTEDO for the treatment of tardive dyskinesia and chorea associated with Huntington disease. The company's products in the respiratory market comprise ProAir, QVAR, ProAir Digihaler, AirDuo Digihaler, and ArmonAir Digihaler, BRALTUS, CINQAIR/CINQAERO, DuoResp Spiromax, and AirDuo RespiClick/ArmonAir RespiClick for the treatment of asthma and chronic obstructive pulmonary disease. Its products in the oncology market include Bendeka, Treanda, Granix, Trisenox, Lonquex, and Tevagrastim/Ratiograstim. Teva Pharmaceutical Industries Limited has a collaboration MedinCell for the development and commercialization of multiple long-acting injectable products, a risperidone suspension for the treatment of patients with schizophrenia. The company was founded in 1901 and is headquartered in Tel Aviv-Yafo, Israel.

Market Cap:
9.22B
Revenue:
15.88B
Total Assets:
47.67B
Total Cash:
2.17B


News about "Teva Pharmaceutical Industries Limited"

teva-pharmaceutical-industries-breaks-above-200-day-moving-average-bullish-for-teva-image

Teva Pharmaceutical Industries Breaks Above 200-Day Moving Average - Bullish for TEVA

Source from : Nasdaq - 8 hours ago

In trading on Tuesday, shares of Teva Pharmaceutical Industries Ltd (Symbol: TEVA) crossed above their 200 day moving average of $8.61, changing hands as high as $8.65 per share. Teva Pharmaceutical ...See details»


raymond-james-trust-na-sells-1526-shares-of-teva-pharmaceutical-industries-limited-nyseteva-image

Raymond James Trust N.A. Sells 1,526 Shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA)

Source from : Defense World - 5 days ago

Raymond James Trust N.A. decreased its holdings in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA โ€“ Get Rating) by 5.1% in the second quarter, according to the company in its most recent ...See details»


Teva reaches settlement with Georgia over price fixing claims

Source from : NJBIZ - 1 days ago

Teva Pharmaceuticals reached an agreement with the state of Georgia to settle price-fixing claims against the pharmaceutical company.See details»


teva-reaches-agreement-with-georgia-to-settle-the-states-price-fixing-claims-image

Teva Reaches Agreement With Georgia to Settle the Stateโ€™s Price Fixing Claims

Source from : YAHOO!Finance - 4 days ago

Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), has reached an agreement with the Attorney General (AG) of Georgia to settle the stateโ€™s ...See details»


Teva To Pay $3.346 Mln To Settle Georgia's Price Fixing Claims

Source from : Business Insider - 4 days ago

Teva Pharmaceuticals, a US arm of Israeli drug maker Teva Pharmaceutical Industries Ltd. (TEVA), said on Friday that it will pay ...See details»


New Suit - Class Action

Source from : Law - 3 month ago

Counsel have not yet appeared for the defendants. The case is 2:21-cv-00477, King County et al v. Teva Pharmaceutical Industries Ltd et al.See details»


Teva Pharm expects to start paying U.S. opioid settlement in 2023 - CEO

Source from : Yahoo News - 16 days ago

TEL AVIV (Reuters) - Teva Pharmaceutical Industries expects to finalise an opioid settlement in the United States by year-end and start paying in 2023, its chief executive said on Sunday, while ...See details»


Teva Launches Honestly HD Website to Provide People Living With Huntington's Disease (HD) Information, Inspiration and Resources on HD Chorea

Source from : Stockhouse - 8 days ago

CloseCurlyDoubleQuote; Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) has been developing and producing medicines to improve people’s lives for more than a century. We are a ...See details»


Teva: Studies Show Efficacy Of Fremanezumab In Patients With Migraine And Major Depressive Disorder

Source from : Business Insider - 26 days ago

(RTTNews) - Teva Pharmaceutical Industries Ltd. (TEVA) reported the results of two studies, which demonstrated the efficacy of AJOVY or fremanezumab in migraine patients who also experience ...See details»


25 Biggest Pharmaceutical Companies in the World A Year Ago

Source from : Insider Monkey - 28 days ago

Market Capitalization as of September 11, 2021: $10.3 billion Market Capitalization as of September 02, 2022: $10 billion Teva Pharmaceutical Industries Limited (NYSE: TEVA) is the 25 th on the ...See details»


Respiratory Inhalers Market : Analysis by Size, Share Trends, Future Growth, Emerging Trends, Qualitative Outlook and Global Forecast to 2028

Source from : MarketWatch - 1 days ago

Respiratory Inhalers Market [1.3% CAGR] 2022 Touching New Heights, Advancing Technologies Helps Prominent Players ...See details»


acute-bacterial-skin-and-skin-structure-infections-market-to-surpass-us-55121-mn-by-2030-image

Acute Bacterial Skin and Skin Structure Infections Market to Surpass US$ 5,512.1 Mn by 2030

Source from : Medgadget - 11 hours ago

Moreover, market players are participating in research and advancement activities for the improvement of new drugs in the treatment of global acute bacterial skin and skin structure infections market.See details»


Studies Show Effectiveness of AJOVYยฎ (fremanezumab) for Treatment of Migraine in Patients With Co-morbid Depression

Source from : Stockhouse - 26 days ago

Teva Pharmaceutical Industries Ltd. today announces the results of two studies1,2 presented at the Migraine Trust International Symposium (MTIS) in London, UK, which demonstrate the efficacy of AJOVY ...See details»


diuretic-drugs-market-to-record-a-cagr-of-544-increasing-incidence-of-hypertension-among-people-to-drive-growth-technavio-image

Diuretic Drugs Market to Record a CAGR of 5.44%, Increasing Incidence of Hypertension Among People to Drive Growth - Technavio

Source from : Yahoo - 5 days ago

The report "Diuretic Drugs Market by Product Type and Geography - Forecast and Analysis 2022-2026" has been added to Technavio's offerings. The market size is anticipated to grow by USD 95.64 million ...See details»